Lagura, Blaze .

HRN: 27-35-41  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/20/2025
06/27/2025
PO
5mL
TID
Intestinal Amoebiasis With Mod DHN
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines